Transcatheter Arterial Infusion of Autologous CD133+ Cells for Diabetic Peripheral Artery Disease
Table 1
Baseline characteristics of patients.
CD133+
Control
(-test)
Age
71.26 ± 9.12
71.62 ± 9.11
0.887
Gender
Male
12
15
0.901†
Female
12
14
Type of DM
Type 1
6
9
0.317†
Type 2
21
17
Hypertension
+
19
21
0.379†
−
8
5
Hyperlipidemia
+
12
4
0.021†
−
15
22
Smoking
+
11
10
0.865†
−
16
16
CAD
+
11
7
0.288†
−
16
19
Hemoglobin, g/L
120.07 ± 16.77
115.77 ± 15.59
0.338
HbA1c, %
8.26 ± 2.08
8.28 ± 2.07
0.954
Serum creatinine, mL/min
80.60 ± 28.73
79.02 ± 22.44
0.824
Total cholesterol, mmol/L
4.55 ± 1.05
4.58 ± 1.02
0.920
Total triglyceride, mmol/L
2.09 ± 2.36
2.47 ± 2.37
0.560
EMG
+
21
20
0.941†
Sensorimotor Polyneuropathy
−
6
6
TASC II
A
0
2
0.440†
B
11
8
C
8
7
D
5
3
No aorta-iliac and femoral-popliteal artery lesions
3
6
Rutherford
0
0
0
0.320†
1
0
1
2
12
5
3
8
10
4
4
5
5
3
5
DM, diabetes mellitus; CAD, coronary artery disease; EMG, electrical test of the muscles; TASC II, Transatlantic Intersociety Consensus II. Value were represented by mean ± SD, -test (†Pearson Chi-Square).
